Table 1.
Change in the most common medications used by the study population pre-operatively to the patients’ last endpointa (n=400)
|
|
||||||
|---|---|---|---|---|---|---|
| Baseline | Last endpoint* | Percent decrease in total study population | Percent decrease among baseline users | |||
|
| ||||||
| n | % | n | % | % | % | |
|
| ||||||
| Antidepressant | 148 | 37.0 | 120 | 30.0 | 7.0 | 18.9 |
| Antihypertensive/diuretic | 131 | 32.8 | 54 | 13.5 | 19.3 | 58.8 |
| ACE/ARBb | 126 | 31.5 | 56 | 14.0 | 17.5 | 55.6 |
| Oral Hypoglycemic | 115 | 28.8 | 40 | 10.0 | 18.8 | 65.2 |
| Statin | 98 | 24.5 | 39 | 9.8 | 14.7 | 60.2 |
| Proton Pump Inhibitor | 88 | 22.0 | 23 | 5.8 | 16.2 | 73.9 |
| Thyroid Hormone | 76 | 19.0 | 72 | 18.0 | 1.0 | 5.3 |
| Benzodiazepine Hypnotic | 56 | 14.0 | 44 | 11.0 | 3.0 | 21.4 |
| Antiepileptic | 55 | 13.8 | 40 | 10.0 | 3.8 | 27.3 |
| Beta Blocker | 48 | 12.0 | 34 | 8.5 | 3.5 | 29.2 |
| Narcotic | 43 | 10.8 | 27 | 6.8 | 4.0 | 37.2 |
| Steroid Anti-inflammatory | 42 | 10.5 | 26 | 6.5 | 4.0 | 38.1 |
| Insulin | 40 | 10.0 | 23 | 5.8 | 4.2 | 42.5 |
a
Last endpoint is either 6 or 12 months post-operative depending on the patient’s post-operative appointment attendance
b
ACE/ARB = Angiotensin converting enzyme inhibitors/Angiotensin II receptor blockers